[1] Yeung-Yue KA, Brentjens MH, Lee PC, et al. Herpes simplex viruses 1 and 2. Dermatol Clin, 2002, 20: 249-266. [2] Mbizvo EM, Msuya Sia E, Stray-Pedersen B, et al. Association of herpes simplex virus type 2 with the human immunodeficiency virus among urban women in Zimbabwe. Int J STD AIDS, 2002, 13: 343-348. [3] Liljeqvist JA, Svennerholm B, Bergstrom T. Conservation of typespecific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates. J Clin Micrubiol, 2000, 38: 4517-4522. [4] Levi M, Ruden U, Wahren B. Peptide sequences of glycoprotein G-2discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin Diagn Lab Inmunol, 1996, 3: 265-269. [5] Grabowska A, Jameson C, Laing P, et al. Identification of typespecific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1. J Gen Virol, 1999,80: 1789-1798. [6] Liljeqvist JA, Trybala E, Svennerholm B, et al. Localization of typespecific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol, 1998, 79:1215-1224. [7] Marsden HS, MacAulay K, Murray J, et al. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J Med Virol, 1998, 56: 79-84. [8] Ikoma M, Liljeqvist JA, Groen J, et al. Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies. J Clin Microbiol, 2002, 40: 2526-2532. [9] 萨姆布鲁克J,拉塞尔DW,等著(黄培堂,等译).分子克隆实验指南.北京:科学出版社,2002.8. |